Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (670)	12/17/2001 2:21:27 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 717

>> I hope that the silence I have encountered thus far is not an indication of complacency on the part of investors. << Hey, we're not chatty in SI biotech. I don't qualify as a PCYC "investor", so I can't speak for them. If I could, I might suggest that you sit on your thumb and spin rapidly.

To: Sam Citron who wrote (670)	12/17/2001 12:39:51 PM
From: Harold Engstrom	Read Replies (1) \| Respond to of 717

Rick's pointer to Peter's earlier post was actually informative, while my post was not really (I apologize.) But, I really think that you intuited the answer that many might like to expound on but don't want to just flame management. I owned PCYC on three separate occaissions - buying when it tanked and selling when it spiked (luckily). The Feuerstein column Peter references sobered me enough to stop considering it after the last purchase. While I owned it, I found out nothing from the company when I called (although they were polite.) I would not buy PCYC at this point. It is analogous to PRCS, which I do own and think is a better play (if you want to live dangerously with a biotech trading at cash.)

To: Sam Citron who wrote (670)	12/17/2001 5:42:28 PM
From: Biomaven	Read Replies (1) \| Respond to of 717

Sam, The release of extremely material information one minute before the close of trading is much more serious. I don't know when the release was made, but looking at the Time and Sales, there was no drop before the close - the last trade was at $22.35 for 100 shares at 16:00:13. There were a few trades after hours near that price, but nothing of any size (the biggest I see is one trade of 6k shares at 16:02) until the trades at the "new" price of around $13.50 at 16:08. Peter